Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (≥ 70 years of age)? arbiter

European Journal of Cancer

Volumn 33, Issue 11, 1997, Pages 1723-1724

  Monfardini, S ^a   Perrone, F ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 11444257773     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00299-2     Document Type: Article

References (9)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992, 339, 1-15, 71-85.
2. Perrone F, De Placido S, Gallo C, et al. Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile. Im J Oncol 1995, 7, 1129-1137.
3. Nixon A, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994, 12, 888-894.
4. Desch CE, Hillner BE, Smith TJ, Retchin SM. Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes. J Clin Oncol 1993, 11, 777-782.
5. Monfardini S, Ferrucci L, Fratino L, et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996, 77, 395-401.
6. Monfardini S, Yancik R. Cancer in the elderly: meeting the challenge of an aging population. J Natl Cancer Inst 1993, 85, 532-538.
7. Monfardini S. What do we know on variables influencing clinical decision-making in elderly cancer patients? Eur J Cancer 1996, 32, 12-14.
8. Osborne CK, Kitten L, Arteaga CL. Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens. J Clin Oncol 1989, 7, 710-717.
9. Fisher B, Redmond C, Lagault-Poisson S, et al. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumor responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-l 6. J Clin Oncol 1990, 8, 1005-1018.